EC Number   |
Inhibitors |
Structure |
|---|
    1.5.3.13 | N,N -di-2,3-butadienyl-1,4-butanediamine |
i.e. MDL 72527, strong inhibition |
   |
| 1.5.3.13 | N,N'-butanedienyl butanediamine |
i.e. MDL 72527 or CPC-200, a small molecule specific inhibitor of polyamine oxidase, effectively blocks androgen-induced reactive oxygen species production in human prostate cancer cells, as well as significantly delays prostate cancer progression and death in animals developing spontaneous prostate cancer |
|
| 1.5.3.13 | N-(3-aminopropyl)-N -2-propenyl-1,4-butanediamine |
moderate inhibition |
|
| 1.5.3.13 | N-(3-aminopropyl)-N -2,3-butadienyl-1,4-butanediamine |
strong inhibition |
|
| 1.5.3.13 | N-prenylagmatine |
- |
|
| 1.5.3.13 | N-[3-(2,3-butadienylamino)propyl]-1,4-butanediamine |
strong inhibition |
|
| 1.5.3.13 | N-[3-(2-propenylamino) propyl]-1,4-butanediamine |
moderate inhibition |
|
| 1.5.3.13 | N1,N1'-(pentane-1,5-diyl)bis[N6-[(2-methoxyphenyl)methyl]hexane-1,6-diamine] |
9fold selectivity for spermine oxidase over polyamine oxidase |
|
| 1.5.3.13 | N1,N4-bis(2,3-butadienyl)-1,4-butanediamine |
i.e. MDL 72,527 |
|
| 1.5.3.13 | N1,N4-bis(2,3-butadienyl)-1,4-butanediamine |
2.5 mM, 70% inhibition of N1-acetylspermine oxidation |
|
